Références
The plantlist: http://www.theplantlist.org/tpl/record/kew-213297
ITIS (Integrated Taxonomic Information System): http://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_ value=32221
Tela botanica: http://www.tela-botanica.org/bdtfx-nn-72745-synthese
Meier B (1999) Probleme des Standardisierung phramazeutischer Zubereitungen. Z Phytother 20:145
Wichtl M, Anton R (2003) Plantes thérapeutiques, tradition, pratique officinale, science et thérapeutique. 2 éd, EMInter/Tec & Doc éditions, Paris
Wikimedia: https://commons.wikimedia.org/wiki/File:Vitexagnus-castus-foliage.JPG
http://www.backyardnature.net/n/14/140316vy.jpg
Kuruüzüm-Uz A, Ströch K, Demirezer LO, et al (2003) Glucosides from Vitex agnus-castus. Phytochemistry 63:959–64
Hirobe C, Qiao ZS, Takeya K, et al (1997) Cytotoxic flavonoids from Vitex agnus-castus. Phytochemistry 46:521–4
Hajdú Z, Hohmann J, Forgo P, et al (2007) Diterpenoids and flavonoids from the fruits of Vitex agnus-castus and antioxidant activity of the fruit extracts and their constituents. Phytother Res 21:391–4
Aissaoui H, Algabr M, Mezhoud S, et al (2016) Chemical constituents of Vitex agnus-castus (Verbenaceae). Pharma Chemica 8:491–4
Hoberg E, Sticher O, Orjala JE, et al (1999) Diterpene aus Agnicasti fructus und ihre Analytik. Z Phytother 20:140–58
Males Z, Blazević N, Antolić A (1998) The essential oil composition of Vitex agnus-castus f. rosea leaves and flowers. Planta Med 64:286–7
Stojkovic D, Sokovic M, Glamočlija J (2011) Chemical composition and antimicrobial activity of Vitex agnus-castus L. fruits and leaves essential oils. Food Chem 128:1017–22
Choudhary MI, Azizuddin, Jalil S, et al (2009) Antiinflammatory and Lipoxygenase Inhibitory Compounds from Vitex agnuscastus Phytother Res 23:1336–9
Liu J, Burdette JE, Xu H, et al (2001) Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 49:2472–9
Jarry H, Leonhardt S, Gorkow C, et al (1994) In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of agnus-castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 102:448–54
Milewicz A, Gejdel E, Sworen H, et al (1993) Vitex agnus-castus extract in the treatment of luteal phase defects due to latent hyperprolactinaemia. Results of a randomized placebocontrolled double blind study. Arnzneimittelforschung 43:752–6
Westphal LM, Polan ML, Trant AS, et al (2004) A nutritional supplement for improving fertility in women. A pilot study. J Reprod Med 49:289–93
Arentz S, Abbott JA, Smith CA, et al (2014) Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratoryevidence for effects with corroborative clinical findings. BMC Complement Altern Med 14:511
Allahtavakoli M, Honari N, Pourabolli I, et al (2015) Vitex agnus-castus extract improves learning and memory and increases the transcription of estrogen receptor α in hippocampus of ovariectomized rats. Basic Clin Neurosci 6:185–92
Sliutz G, Speiser P, Schultz AM, et al (1993) Agnus-castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 25:253–5
Jarry H, Leonhardt S, Spengler B, et al (1999) Auf der suche nach dopaminergen substanzen in agnicasti- fructus-präparaten: warum eigentlich? Z Phytother 20:140–58
Halaška M, Beles P, Gorkow C, et al (1999) Treatment of cyclical mastalgia with a solution containing a Vitex agnus-castus extract: results of a placebo-controlled double-blind study. Breast 8:175
Wuttke W, Jarry H, Christoffel V, et al (1997) Behandlung zyklusabhängiger Brustschmerzen mit einem agnus-castus-haltigen Arzneimittel. Geburtshilfe Frauenheilkd 57:1–14
Webster DE, Lu J, Chen SN, et al (2006) Activation of the μ- opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS. J Ethnopharmacol 106:216–21
Brugisser R, Burkhard W, Simmen U, et al (1999) Untersuchungen an opioid-rezeptoren mit Vitex agnus-castus L. Z Phytother 20:140–58
Schellenberg R (2001) Treatment for the premenstrual syndrome with agnus-castus fruit extract: prospective, randomised, placebo controlled study. BMJ 322:134–7
Atmaca M, Kumru S, Tezcan E, et al (2003) Fluoxetine versus Vitex agnus-castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacol Clin Exp 18:191–5
Loch EG, Selle H, Boblitz N (2000) Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus-castus. J Womens Health Gend Based Med 9:315–20
Berger D, Schaffner W, Schrader E, et al (2000) Efficacy of Vitex agnus-castus L. extract Ze 440 in patients with premenstrual syndrome (PMS). Arch Gynecol Obstet 264:150–3
Lauritzen CH, Reuter HD, Repges R, et al (1997) Treatment of premenstrual tension syndrome with Vitex agnus-castus controlled, double-blind study versus pyridoxine. Phytomedicine 4:183–9
Dericks-Tan JSE, Schwinn P, Hildt C (2003) Dose-dependent stimulation of melatonin secretion after administration of agnuscastus. Exp Clin Endocrinol Diabetes 111:44–6
Liou CJ, Len WB, Wu SJ, et al (2014) Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. J Ethnopharmacol 158 pt A:310–6
Eftekhari MH, Rostami ZH, Emami MJ, et al (2014) Effects of “ Vitex agnus-castus” extract and magnesium supplementation, alone and in combination, on osteogenic and angiogenic factors and fracture healing in women with long bone fracture. J Res Med Sci 19:1–7
Merz PG, Gorkow C, Schrödter A, et al (1996) The effects of a special agnus-castus (BP1095E1) on prolactin secretion in healthy male subjects. Exp Clin Endrocrinol Diabetes 104:447–53
Brattsrtöm A, Kaiser WD (2010) Das Restless-legs-Syndrom (RLS) — Erfahrungsbericht mit einem Vitex agnus-castus (VAC)-Extrakt. Z Phytother 31:247–50
Detienne M (1972) Les jardins d’Adonis, la mythologie des aromates en Grèce. NRF, Gallimard, Paris
Daniele C, Thompson-Coon J, Pittler MH (2005) Vitex agnuscastus: a systematic review of adverse events. Drug Saf 28:319–32
Bibliographie institutionnelle
American Herbal Pharmacopoeia, BHP 1996, BP 2007, BHMA 2003, Complete German Commission E 1998, ESCOP 2003, Martindale 35th edition, PhEur 2007, WHO Monographs on Selected Medicinal Plants 2009
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ghedira, K., Goetz, P. Gattilier. Phytothérapie 14, 264–268 (2016). https://doi.org/10.1007/s10298-016-1061-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10298-016-1061-4